(1)
Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy. Mediterr J Hematol Infect Dis 2024, 16 (1), e2024049. https://doi.org/10.4084/MJHID.2024.049.